Skip to product information
1 of 1
Out of Stock

Erli Plus (Empagliflozin + Metformin) 12.5/1000mg, 14 Ct - PharmEvo

Erli Plus (Empagliflozin + Metformin) 12.5/1000mg, 14 Ct - PharmEvo

Regular price PKR 277
Regular price Sale price PKR 277
Out of Stock
Pack Size: 14 Film Coated Tablets
Erli Plus is a prescription combination medication containing Empagliflozin (12.5 mg) and Metformin Hydrochloride (1000 mg). It is used as an adjunct to diet and exercise to improve glycemic control...  Read More
Brand: PharmEvo
SKU: 08964003195014
Country: Pakistan
View full details

Description

Erli Plus is a prescription combination medication containing Empagliflozin (12.5 mg) and Metformin Hydrochloride (1000 mg). It is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are not adequately controlled on a regimen containing empagliflozin or metformin, or in patients already being treated with both medications. The two active ingredients work through complementary mechanisms: Empagliflozin (an SGLT2 inhibitor) blocks glucose reabsorption in the kidneys, increasing glucose excretion in urine, while Metformin (a biguanide) reduces glucose production in the liver and improves insulin sensitivity

  • Dual-Action Blood Sugar Control: Combines two complementary mechanisms SGLT2 inhibition (Empagliflozin) and reduced hepatic glucose production (Metformin) for enhanced glycemic control
  • Cardiovascular Risk Reduction: Empagliflozin has been shown to reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease
  • Supports Weight Management: May promote modest weight loss in diabetic patients
  • Improves Insulin Sensitivity: Metformin increases peripheral glucose uptake and utilization, helping cells respond better to insulin

Composition
Each film coated tablet contains:

  • Empagliflozin: 12.5 mg
  • Metformin HCI USP: 1000 mg
    (As per innovator's specs)

Directions for Use

  • Use as advised by the physician

Legal Disclaimer

Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.

Collapsible content

Product Overview

Erli Plus is a prescription combination medication containing Empagliflozin (12.5 mg) and Metformin Hydrochloride (1000 mg). It is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are not adequately controlled on a regimen containing empagliflozin or metformin, or in patients already being treated with both medications. The two active ingredients work through complementary mechanisms: Empagliflozin (an SGLT2 inhibitor) blocks glucose reabsorption in the kidneys, increasing glucose excretion in urine, while Metformin (a biguanide) reduces glucose production in the liver and improves insulin sensitivity

  • Dual-Action Blood Sugar Control: Combines two complementary mechanisms SGLT2 inhibition (Empagliflozin) and reduced hepatic glucose production (Metformin) for enhanced glycemic control
  • Cardiovascular Risk Reduction: Empagliflozin has been shown to reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease
  • Supports Weight Management: May promote modest weight loss in diabetic patients
  • Improves Insulin Sensitivity: Metformin increases peripheral glucose uptake and utilization, helping cells respond better to insulin

Composition
Each film coated tablet contains:

  • Empagliflozin: 12.5 mg
  • Metformin HCI USP: 1000 mg
    (As per innovator's specs)

Directions for Use

  • Use as advised by the physician

Legal Disclaimer

Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.

Product Overview

Erli Plus is a prescription combination medication containing Empagliflozin (12.5 mg) and Metformin Hydrochloride (1000 mg). It is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are not adequately controlled on a regimen containing empagliflozin or metformin, or in patients already being treated with both medications. The two active ingredients work through complementary mechanisms: Empagliflozin (an SGLT2 inhibitor) blocks glucose reabsorption in the kidneys, increasing glucose excretion in urine, while Metformin (a biguanide) reduces glucose production in the liver and improves insulin sensitivity

  • Dual-Action Blood Sugar Control: Combines two complementary mechanisms SGLT2 inhibition (Empagliflozin) and reduced hepatic glucose production (Metformin) for enhanced glycemic control
  • Cardiovascular Risk Reduction: Empagliflozin has been shown to reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease
  • Supports Weight Management: May promote modest weight loss in diabetic patients
  • Improves Insulin Sensitivity: Metformin increases peripheral glucose uptake and utilization, helping cells respond better to insulin

Composition
Each film coated tablet contains:

  • Empagliflozin: 12.5 mg
  • Metformin HCI USP: 1000 mg
    (As per innovator's specs)

Directions for Use

  • Use as advised by the physician

Legal Disclaimer

Unless expressly indicated in the product description, MyVitaminStore.pk is not the manufacturer of the products sold on our website. While we work to ensure that product information on our website is correct, manufacturers may alter their product information. Actual product packaging and materials may contain more and/or different information than shown on our website. If you have any specific product queries, please contact the manufacturer. For medicinal products, content on our website is not intended to be used to diagnose, treat, cure, or prevent any disease or health condition or to substitute advice given by medical practitioners, pharmacists or other licensed health care professionals. You should contact your health care provider immediately if you suspect that you have a medical problem. You should always read the labels, warnings and instructions provided with the product before using or consuming it and not solely rely on the information presented on our website.